Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Animal Experimentation and Research (1)
- Biology (1)
- Diseases (1)
- Immunology and Infectious Disease (1)
- Integrative Biology (1)
-
- Life Sciences (1)
- Medicinal Chemistry and Pharmaceutics (1)
- Microbiology (1)
- Nanomedicine (1)
- Nanotechnology (1)
- Organic Chemicals (1)
- Other Immunology and Infectious Disease (1)
- Pharmaceutical Preparations (1)
- Pharmacology (1)
- Pharmacology, Toxicology and Environmental Health (1)
- Research Methods in Life Sciences (1)
- Virology (1)
- Virus Diseases (1)
Articles 1 - 2 of 2
Full-Text Articles in Chemicals and Drugs
Near Infrared Gumbos And Nanogumbos For Biomedical Applications, Mi Chen
Near Infrared Gumbos And Nanogumbos For Biomedical Applications, Mi Chen
LSU Doctoral Dissertations
Recent advances in development of nanomaterials have provided great opportunities for cancer research. In this dissertation, nanoGUMBOS derived from a group of uniform materials based on organic salts (GUMBOS) were investigated for several biomedical applications including chemotherapy, photothermal therapy (PTT), and drug delivery. GUMBOS are solid-phase organic salts consisting of bulky cations and anions. Similar to ionic liquids, GUMBOS display highly tunable properties with counter-ions variation, but with a defined melting point range of 25–250 °C. Nanomaterials derived from GUMBOS, i.e. nanoGUMBOS, display enhanced properties at the nanoscale level. This dissertation focuses on development of near infrared IR780 nanoGUMBOS for …
Development Of A Long-Acting Nanoformulation Of Dolutegravir For Prevention And Treatment Of Hiv-1 Infection, Brady Sillman
Development Of A Long-Acting Nanoformulation Of Dolutegravir For Prevention And Treatment Of Hiv-1 Infection, Brady Sillman
Theses & Dissertations
Dolutegravir (DTG) is a potent human immunodeficiency virus type 1 (HIV-1) integrase strand-transfer inhibitor (INSTI) with a high barrier to viral drug resistance. However, opportunities to improve its profile abound. These include extending the drug’s apparent half-life, increasing penetrance to “putative” viral reservoirs, and reducing inherent toxicities. These highlight, in part, the need for long-acting, slow effective release antiretroviral therapy (LASER ART) delivery schemes. A long-acting (LA) DTG was made by synthesizing a hydrophobic and lipophilic prodrug encased with poloxamer (P407) surfactant. This modified DTG (MDTG) reduced systemic metabolism and polarity, increased lipophilicity and membrane permeability, improved encapsulation, and formed …